Details for 2020169707

Up to date per 02.04.2026

Actions

Title / Product Name

KRISTALLINE FORM VON (S)-N-(5-((R)-2-(2,5-DIFLUORPHENYL)-PYRROLIDIN-1-YL)-PYRAZOLO[1,5-A]PYRIMIDIN-3-YL)-3-HYDROXYPYRROLIDIN-1-CARBOXAMID-SCHWEFELWASSERSTOFF

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2020169707

EP Publication Number

3699181

E-Number

1550913

Language

PCT Number

Publication Date

26.08.2020 A

01.03.2023 B1

Registration Date

01.03.2023

AT Publication Date

15.03.2023

Application Date

16.11.2015

Registration Number

Priorities

16.11.2014

201462080374 P

01.06.2015

201562169545 P

IPC

C07D 487/04 20060101AFI20200617BHEP

Maximum Duration of Protection

16.11.2035

Owner

Array Biopharma, Inc.3200 Walnut Street Boulder, CO 80301US

Representative

Authorized Recipients

Dr. Markus Zollerc/o HGF Europe LLP, Rudolfskai 485020 SalzburgAT

Inventor

ARRIGO, Alisha B.Array Biopharma, Inc 3200 Walnut Street Boulder, CO 80301US

JUENGST, DerrickArray Biopharma, Inc. 3200 Walnut Street Boulder, CO 80301US

SHAH, Khalid12 Amberwood Circle South San Francisco, CA 94080US

Information about Fees